Salvage treatment of multi-refractory primary immune thrombocytopenia with CD19 CAR T cells
Lancet
.
2025 Jan 4;405(10472):25-28.
doi: 10.1016/S0140-6736(24)02504-2.
Authors
Karolin Trautmann-Grill
1
,
Malte von Bonin
1
,
Annabell Georgi
1
,
Jan Moritz Middeke
1
,
Martin Böttcher
2
,
Oliver Meyer
3
,
Dominic Borie
4
,
Martin Bornhäuser
1
,
Martin Mikusko
2
,
Denise Wolleschak
2
,
Dimitrios Mougiakakos
5
Affiliations
1
Medical Clinic I, TU Dresden, Dresden, Germany.
2
Department of Hematology, Oncology, and Cell Therapy, Otto-von-Guericke University, Magdeburg 39120, Germany.
3
German Red Cross Blood Service NSTOB, Springe, Germany.
4
Kyverna Therapeutics, Emeryville, CA, USA.
5
Department of Hematology, Oncology, and Cell Therapy, Otto-von-Guericke University, Magdeburg 39120, Germany. Electronic address:
[email protected]
.
PMID:
39755385
DOI:
10.1016/S0140-6736(24)02504-2
No abstract available
Publication types
Letter